PMID 26009073 26009073 DOI 10.1016/j.preghy.2011.08.043 10.1016/j.preghy.2011.08.043
Cite this article
D'Anna, R., Benedetto, V., Rizzo, P., Raffone, E., Interdonato, M. L., Licata, G., Corrado, F., & Di Benedetto, A. (2011). O11. Myo-inositol may prevent metabolic and hypertensive disorders in PCOS pregnant women. *Pregnancy Hypertension*, *1*(3-4), 262. https://doi.org/10.1016/j.preghy.2011.08.043
D'Anna R, Benedetto V, Rizzo P, Raffone E, Interdonato ML, Licata G, et al. O11. Myo-inositol may prevent metabolic and hypertensive disorders in PCOS pregnant women. Pregnancy Hypertens. 2011;1(3-4):262. doi:10.1016/j.preghy.2011.08.043
D'Anna, R., et al. "O11. Myo-inositol may prevent metabolic and hypertensive disorders in PCOS pregnant women." *Pregnancy Hypertension*, vol. 1, no. 3-4, 2011, pp. 262.
Melo P et al., 2023
Open Access
BJOG : an International Journal of Obstetrics and Gynaecology
Background: Treatment with vaginal progesterone reduces the risk of miscarriage and preterm birth in selected high-risk women. The hypothesis that vaginal progesterone can reduce the risk of hypertens...
Kashyap S et al., 2001The Journal of Reproductive Medicine
OBJECTIVE: To compare the incidence of pregnancy-induced hypertension in patients with and without polycystic ovary disease (PCOD).
STUDY DESIGN: We conducted a retrospective, case-control analysis o...
Salha O et al., 1999Human Reproduction (Oxford, England)
Pregnancies achieved from oocyte, sperm or embryo donation are unique, since they have resulted from donor gametes that are immunologically foreign to the mother. Thus, studying the obstetric outcome ...